Background illustration for clinical trials search

Migraine Clinical Trials

Browse 103 migraine clinical trials enrolling across the United States and Canada. 86 people applied to migraine studies last month. Search by city or state to find one near you.

Filter
1

Clinical Trial of Endoscopically Guided Injection of Exparel (Bupivacaine) for the Treatment of Craniofacial Pain

for
Craniofacial Pain, Migraine, Cluster Headache,
Location: Stanford CA
Sponsor: Stanford University

Sex: All

Age: 18 - 70+

Code: NCT04930887

Phase2, Recruiting

Randomized Study in Children and Adolescents With Migraine: Acute Treatment

for
Pediatric Migraine
Location: East Greenwich RI, Cromwell CT, Commack NY, Stamford CT,
Sponsor: Pfizer

Sex: All

Age: 6 - 17

Code: NCT04649242

Phase3, Recruiting

Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine

for
Acute Treatment of Migraine
Location: East Greenwich RI, Cromwell CT, Commack NY, Stamford CT,
Sponsor: Pfizer

Sex: All

Age: 6 - 17

Code: NCT04743141

Phase3, Recruiting

Determining the Utility of a Behavioral Intervention in Chronic Migraine

for
Migraine, Headache, Migraine Disorders, Chronic Migraine,
Location: Phoenix AZ
Sponsor: Mayo Clinic

Sex: All

Age: 18+

Code: NCT05415020

Recruiting

Validating a Modified COMPASS 31questionnaire for Treatment Outcomes

for
Headache, Migraine, Persistent Post Traumatic Headache,
Location: Houston TX
Sponsor: Brooke Army Medical Center

Sex: All

Age: 18 - 64

Code: NCT05302479

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Study of Low-dose Naltrexone in Chronic Migraine With Fibromyalgia

for
Chronic Migraine, Fibromyalgia, New Daily Persistent Headache
Location: Philadelphia PA
Sponsor: Thomas Jefferson University

Sex: All

Age: 18+

Code: NCT05536050

Recruiting

The Effect of Daylight Saving Time Transitions on Sleep and Migraine Headaches.

for
Episodic Migraine
Location: Peoria IL
Sponsor: OSF Healthcare System

Sex: All

Age: 18+

Code: NCT05742191

Recruiting

Cannabis for Chronic Headaches in Adolescents: the CAN-CHA Trial

for
Chronic Migraine
Location: Toronto
Sponsor: University of Manitoba

Sex: All

Age: 14 - 17

Code: NCT05337033

Phase2, Recruiting

Mechanisms of Alcohol Sensitivity in AERD

for
Aspirin-Sensitive Asthma With Nasal Polyps, Samter's Syndrome
Location: Charlottesville VA
Sponsor: University of Virginia

Sex: All

Age: 21+

Code: NCT03441438

Recruiting

Assessing Pharmacokinetics and Pharmacodynamics of Daily Enteric-coated Aspirin in Patients With StablE Diabetes II

for
Platelet Aggregation, Type 2 Diabetes, Aspirin,
Location: Montreal
Sponsor: Montreal Heart Institute

Sex: All

Age: 18+

Code: NCT05702463

Phase1, Recruiting

The PARTUM Trial: Postpartum Aspirin to Reduce Thromboembolism Undue Morbidity

for
Venous Thromboembolism, Postpartum Period, Aspirin,
Location: Calgary
Sponsor: University of Calgary

Sex: Female

Age: 18+

Code: NCT06494878

Phase3, Recruiting

Tranexamic Acid for Second Trimester Dilation and Evacuation and Bleeding Outcomes

for
Abortion, Dilation and Evacuation, Hemorrhage,
Location: Chicago IL, San Diego CA
Sponsor: University of California, San Diego

Sex: Female

Age: 18+

Code: NCT06820177

Recruiting

Topical Intranasal Anesthetic Block for Reducing the Pain of Botulinum Toxin Injections for Chronic Migraine

for
Pain From onabotulinumtoxinA Injections
Location: East Providence RI
Sponsor: Association of Migraine Disorders

Sex: All

Age: 18+

Code: NCT07571889

Recruiting

Treatment of Meniere's Disease With Migraine Medications

for
Ménière
Location: Orange CA
Sponsor: University of California, Irvine

Sex: All

Age: 25 - 70+

Code: NCT05582837

Recruiting
FeaturedActive & Responsive

A Study to Investigate the Safety and Efficacy of MEDI0618 Compared to Placebo in Adult Participants With Episodic Migraine

for
Migraine
Location: Miami FL, Los Angeles CA, Summerville SC, Tampa FL,
Sponsor: AbbVie

Sex: All

Age: 18 - 70

Code: NCT06602479

Phase2, Recruiting
Active & Responsive

Pilot Study for a Machine Learning Test for Migraine

for
Migraine, Chronic Migraine, Tension-Type Headache
Location: Toronto
Sponsor: Headache Sciences Incorporated

Sex: All

Age: 18 - 70

Code: NCT05517200

Not recruiting

Study of Low-level Laser Therapy in the Acute Treatment of Migraine

for
Migraine Headache
Location: San Francisco CA
Sponsor: The San Francisco Clinical Research Center

Sex: All

Age: 18+

Code: NCT02969642

Phase2, Recruiting

Treximet in Acute Migraine Headache: Assessing Cognitive Function

for
Migraine Headache, Cognitive Impairment
Location: Bennington VT
Sponsor: Neurological Research Center

Sex: All

Age: 18 - 65

Code: NCT00837044

Recruiting

Unhide® Project: A Digital Health Platform to Collect Lifestyle Data for Brain Inflammation Research

for
Post-Acute COVID-19 Syndrome, ME/CFS, Rheumatic Arthritis,
Location: Delafield WI
Sponsor: Brain Inflammation Collaborative

Sex: All

Age: 2+

Code: NCT04806620

Recruiting

BE WELL With Migraine: Brain Education and WELLness With Migraine

for
Migraine
Location: Winston-Salem NC
Sponsor: Wake Forest University Health Sciences

Sex: All

Age: 18+

Code: NCT05987592

Recruiting

What is migraine?

Migraine is a brain condition, not a blood vessel problem or a stress reaction. An attack usually brings throbbing pain on one side of the head, along with nausea and sensitivity to light and sound, and it can last from a few hours to three days. About 1 in 4 people with migraine get an aura first, visual disturbances like flashing lights or zigzag lines that come before the pain. Doctors sort migraine by frequency: episodic means fewer than 15 headache days a month, chronic means 15 or more, with at least 8 of them migraine days, for more than three months.

For most of medical history, migraine was treated with medicines borrowed from other conditions: blood pressure pills, antidepressants, epilepsy drugs. That changed in 2018, when the first medicine designed specifically for migraine was approved. It blocks a molecule called CGRP, which the brain releases during an attack. There are now four CGRP antibodies given by injection and several CGRP blocking pills, called gepants, and they treat both attacks and prevention. In a 2025 real world study of more than 2,000 patients, about 47 percent of people on a CGRP antibody had a meaningful response at three months, compared with about 35 percent on traditional preventives.

Types of migraine clinical trials

Who can participate in migraine clinical trials?

Episodic and chronic migraine, and why the line matters for trials

Do migraine trial participants get paid?

What is the difference between a migraine and a headache?

How to Enroll in a Clinical Trial for Migraine